Purpose: The pharmacology, pharmacokinetics ... for patients who do not benefit from or are unable to tolerate other antidepressant therapy. Conclusion: Duloxetine has been approved for the ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

After the U.S. Food and Drug Administration recalled thousands of bottles of antidepressants it said contained high levels of a cancer-causing chemical, the federal agency has now upgraded the level ...

Purpose: The pharmacology, pharmacokinetics ... Atomoxetine is a methylphenoxy-benzenepropanamine derivative with antidepressant activity and is thought to enhance noradrenergic function via ...

Over 7,000 bottles of the antidepressant medication duloxetine ... an associate professor of pharmacology and toxicology at ...

All marketed antidepressants are based in clinical ... more resilient brain serotonin system, a pharmacology distinct from available serotonin drugs, e.g., serotonin reuptake inhibitors and ...